Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

CATCo appointments strengthen underwriting team

24 Feb 2014 07:00

RNS Number : 6964A
CATCo Reinsurance Opps Fund Ltd
24 February 2014
 



 

 

24 February 2014

 

PRESS RELEASE

CATCO STRENGTHENS ITS UNDERWRITING TEAM

 

CATCo Investment Management ("CATCo"), the specialist insurance linked securities manager, announces the appointments of Charles Vaughan and Richard Montgomerie as Directors of Underwriting. Based in London, Charles and Richard will join the existing underwriting team on 1 March 2014 reporting to Anthony Belisle, Chief Executive Officer, and Jason Bibb, Chief Operating Officer and Chief Financial Officer. The appointments of Charles and Richard will play a key role as CATCo looks to further diversify its current investment strategies.

 

Both Charles and Richard have extensive reinsurance underwriting experience, 37 and 30 years respectively, and through their global contacts within the reinsurance sector will bring considerable value to CATCo's existing underwriting process.

 

Prior to joining CATCo, Charles and Richard's reinsurance underwriting experience included co-founding reinsurance strategies for asset managers AQR Capital Management and Magnetar Capital.

 

Tony Belisle, Chief Executive Officer of CATCo Investment Management Ltd., said:

 

"CATCo's priority is to bring solutions to our reinsurance counterparties while at the same time delivering attractive returns to our investors. To deliver on these objectives requires having the strongest underwriting capability available in well diversified strategies.

 

"With their depth of knowledge, Charles and Richard bring exceptional levels of expertise, as well as proven track records, which will combine seamlessly with CATCo's existing underwriting team. These appointments demonstrate our continued commitment to hiring high quality people who can help enhance our reinsurance product and investment fund offering."

Charles Vaughan and Richard Montgomerie, Directors of Underwriting, said jointly:

 

"In a short space of time CATCo has become an established manager in the reinsurance space with highly professional people and a strong brand. The senior management has built a very impressive team and product range in a relatively short period of time. The Company has the right leadership with a strong vision to meet the changing needs of the market, so we are very excited to be joining the firm at this time and we look forward to working with our new colleagues in the months and years ahead.

 

'Ends'

 

 

 

 

 

For further information, please contact:

 

Mark Way

Corporate Communications Director

CATCo Investment Management Ltd

Telephone: +44 7786 116991

mark.way@catcoim.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGZZRZGGDZG
Date   Source Headline
18th Dec 20241:48 pmRNSResult of Meeting
18th Dec 20247:30 amRNSSuspension - CATCo Reinsurance Opps Fund Ltd
18th Dec 20247:00 amRNS3rd Quarter Results
22nd Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
18th Nov 20247:00 amRNSCirc re. Proposed winding up and notice of SGM
13th Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
29th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
27th Sep 20243:05 pmRNSHalf-year Report
4th Sep 20247:00 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSNet Asset Value(s)
5th Jun 20242:21 pmRNSResult of AGM
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.